missing translation for 'onlineSavingsMsg'
Learn More
Learn More
Invitrogen™ Human PCID1 (aa 36-178) Control Fragment Recombinant Protein
Click to view available options
Quantity:
100 μL
Unit Size:
100µL
Description
Highest antigen sequence indentity to the following orthologs: Mouse (99%), Rat (99%). This recombinant protein control fragment may be used for blocking experiments with the corresponding antibody, PA5-56626 (PA5-56626. In IHC/ICC and WB experiments, we recommend a 100x molar excess of the protein fragment control based on the concentration and the molecular weight. Pre-incubate the antibody-protein control fragment mixture for 30 min at room temperature.
This gene encodes a protein that is part of the eurkaryotic translation initiation factor 3 complete (eIF-3) required for protein synthesis. Elevated levels of the encoded protein are present in cancer cell lines. Inactivation of the encoded protein has been shown to interfere with translation of herpes virus mRNAs by preventing the association of mRNAs with the ribosomes. A pseudogene of this gene is located on the X chromosome.
Specifications
Specifications
| Accession Number | Q7L2H7 |
| Concentration | ≥5.0 mg/mL |
| For Use With (Application) | Blocking Assay, Control |
| Formulation | 1 M urea, PBS with no preservative; pH 7.4 |
| Gene ID (Entrez) | 10480 |
| Name | Human PCID1 (aa 36-178) Control Fragment |
| Quantity | 100 μL |
| Regulatory Status | RUO |
| Gene Alias | B5; B5 receptor; dendritic cell protein; dendritic cell protein GA17; eIF3m; Eukaryotic translation initiation factor 3 subunit M; eukaryotic translation initiation factor 3, subunit M; fetal lung protein B5; FLJ29030; GA17; HFLB5; hFL-B5; PCI domain containing 1 (herpesvirus entry mediator); PCI domain-containing protein 1; PCID1; PNAS-125; RGD1565840; Tango7; transport and golgi organization 7 homolog |
| Common Name | PCID1 |
| Show More |
Product Content Correction
Your input is important to us. Please complete this form to provide feedback related to the content on this product.
Product Title
Spot an opportunity for improvement?Share a Content Correction